Abacus FCF Advisors’s Pfizer PFE Stock Holding History

Abacus FCF Advisors’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-1,033	Closed	-$37.9K	–	150
2023 Q2	$37.9K	Sell	1,033 -30,996	-97%	-$1.21M	0.02%	134
2023 Q1	$1.31M	Sell	32,029 -9,369	-23%	-$405K	0.7%	45
2022 Q4	$2.12M	Sell	41,398 -933	-2%	-$44.7K	1.38%	9
2022 Q3	$1.85M	Sell	42,331 -9,304	-18%	-$452K	1.28%	9
2022 Q2	$2.71M	Sell	51,635 -46,227	-47%	-$2.36M	1.66%	5
2022 Q1	$5.07M	Buy	97,862 +45,516	+87%	+$2.36M	1.7%	5
2021 Q4	$3.09M	Buy	+52,346	New	+$2.59M	1.52%	7
2015 Q3	–	Sell	-74,917	Closed	-$2.38M	–	131
2015 Q2	$2.38M	Buy	74,917 +8,811	+13%	+$287K	1.04%	61
2015 Q1	$2.18M	Buy	66,106 +7,032	+12%	+$224K	1.07%	17
2014 Q4	$1.75M	Buy	+59,074	New	+$1.69M	1.07%	48

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Abacus FCF Advisors's PFE Position: Q3 2023 in Review

Abacus FCF Advisors sold out of Pfizer (PFE) in Q3 2023, closing a stake of 1,033 shares — an estimated $37.9K sold.

Abacus FCF Advisors first reported a position in PFE in Q4 2014 and held it in 10 quarters. The position peaked at $5.07M in Q1 2022. 2,925 funds tracked by Wall St. Rank hold PFE as of Q3 2023.

Abacus FCF Advisors reported no remaining Pfizer position as of Q3 2023 after selling out during the quarter.
Abacus FCF Advisors sold 1,033 Pfizer shares in Q3 2023, an estimated $37.9K.
Abacus FCF Advisors first reported a position in Pfizer in Q4 2014 and held it in 10 quarters.
Abacus FCF Advisors's Pfizer position peaked at $5.07M in Q1 2022.
2,925 funds tracked by Wall St. Rank held Pfizer as of Q3 2023.

Based on Abacus FCF Advisors's 13F filing for Q3 2023, filed 10 Oct 2023.